Expert Opinion on Drug Metabolism and Toxicology 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Metabolic and toxicological considerations of Bruton ’s tyrosine kinase inhibitors for the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma
Volume 20, Issue 4, April 2024, Page 207-224 . (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - March 25, 2024 Category: Drugs & Pharmacology Authors: Anna Wolska-WasherPawe ł RobakMagdalena WitkowskaTadeusz Robaka Department of Hematology, Medical University of Lodz, Lodz, Polandb Department of Hematooncology, Copernicus Memorial Hospital, Lodz, Polandc Department of General Hematology, Copernicus Mem Source Type: research
Metabolic and toxicological considerations of Bruton ’s tyrosine kinase inhibitors for the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - March 25, 2024 Category: Drugs & Pharmacology Authors: Anna Wolska-WasherPawe ł RobakMagdalena WitkowskaTadeusz Robaka Department of Hematology, Medical University of Lodz, Lodz, Polandb Department of Hematooncology, Copernicus Memorial Hospital, Lodz, Polandc Department of General Hematology, Copernicus Mem Source Type: research
Predictive Modelling in pharmacokinetics: from in-silico simulations to personalized medicine
Volume 20, Issue 4, April 2024, Page 181-195 . (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - March 21, 2024 Category: Drugs & Pharmacology Authors: Ajita PaliwalSmita JainSachin KumarPranay WalMadhusmruti KhandaiPrasanna Shama KhandigeVandana SadanandaMd. Khalid AnwerMonica GulatiTapan BehlShriyansh Srivastavaa Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Great Source Type: research
Predictive Modelling in pharmacokinetics: from in-silico simulations to personalized medicine
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - March 21, 2024 Category: Drugs & Pharmacology Authors: Ajita PaliwalSmita JainSachin KumarPranay WalMadhusmruti KhandaiPrasanna Shama KhandigeVandana SadanandaMd. Khalid AnwerMonica GulatiTapan BehlShriyansh Srivastavaa Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Great Source Type: research
Metabolism, toxicity and management of fruquintinib: a novel drug for metastatic colorectal cancer
Volume 20, Issue 4, April 2024, Page 197-205 . (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - March 20, 2024 Category: Drugs & Pharmacology Authors: Kanchi PatellVeronica Lee MearsMichael H. StorandtAmit Mahipala Hematology and Oncology Fellow, University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USAb GI Oncology Clinical Pharmacist Specialist, University Hospita Source Type: research
Metabolism, toxicity and management of fruquintinib: a novel drug for metastatic colorectal cancer
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - March 20, 2024 Category: Drugs & Pharmacology Authors: Kanchi PatellVeronica Lee MearsMichael H. StorandtAmit Mahipala Hematology and Oncology Fellow, University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USAb GI Oncology Clinical Pharmacist Specialist, University Hospita Source Type: research
Risk factors associated with high-dose methotrexate induced toxicities
Volume 20, Issue 4, April 2024, Page 263-274 . (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - March 19, 2024 Category: Drugs & Pharmacology Authors: Wenshu LiJiayi MoZhilin YangZhigang ZhaoShenghui Meia Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, P. R. Chinab Department of Clinical Pharmacology, College of Pharmaceutical Sciences, Capital Medical University, Source Type: research
Risk factors associated with high-dose methotrexate induced toxicities
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - March 19, 2024 Category: Drugs & Pharmacology Authors: Wenshu LiJiayi MoZhilin YangZhigang ZhaoShenghui Meia Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, P. R. Chinab Department of Clinical Pharmacology, College of Pharmaceutical Sciences, Capital Medical University, Source Type: research
A comprehensive update on the ADMET considerations for α2δ calcium channel ligand medications for treating restless legs syndrome
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - March 15, 2024 Category: Drugs & Pharmacology Authors: Gaia PellitteriSalvatore VersaceGiovanni MerlinoAnnacarmen NiloGian Luigi GigliMariarosaria Valentea Clinical Neurology Unit, Udine University Hospital, Udine, Italyb Department of Medicine (DMED), University of Udine, Udine, Italy Source Type: research
Beyond the hype and toward application: liver complex in vitro models in preclinical drug safety
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - March 13, 2024 Category: Drugs & Pharmacology Authors: Sushma JadalannagariLorna EwartDepartment of Bioinnovations, Emulate Inc, Boston, MA, USA Source Type: research
Cannabidiol: metabolism and clinical efficacy in epileptic patients
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - March 13, 2024 Category: Drugs & Pharmacology Authors: Giovanni Battista Dell ’isolaAlberto VerrottiMiriam SciaccalugaGianluca DiniPietro FerraraLucilla ParnettiCinzia Costaa Department of Pediatrics, University of Perugia, Perugia, Italyb Section of Neurology, Laboratory of Experimental Neurology, Departme Source Type: research
Drug interactions of carbonic anhydrase inhibitors and activators
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - March 11, 2024 Category: Drugs & Pharmacology Authors: Claudiu T. SupuranNeurofarba Department, Pharmaceutical and Nutraceutical Section, University of Florence, Sesto Fiorentino, FI, Italy Source Type: research
What is the impact of metabolic dysfunction –associated steatotic liver disease on drug transport and metabolism?
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - March 5, 2024 Category: Drugs & Pharmacology Authors: Christoph G. DietrichAndreas Geiera Gastroenterology Practice and Liver-Center Wiesbaden, Wiesbaden, Germanyb Division of Hepatology, Department of Medicine II, University Hospital Wuerzburg (UKW), W ürzburg, Germany Source Type: research
How can we optimize the use of methotrexate to treat pediatric patients with inflammatory skin diseases?
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - March 4, 2024 Category: Drugs & Pharmacology Authors: Kajetan Kie łbowskiEstera BakinowskaAndrzej PawlikDepartment of Physiology, Pomeranian Medical University, Szczecin, Poland Source Type: research
